C-201Government of CanadaCONSERVATIVE
An Act to amend the Canada Health Act (mental, addictions and substance use health services)
Tests whether drug-price transparency is a non-partisan issue. Backed by patient-advocacy groups; opposed by industry.
Status
✓
Introduced✓
1st Reading3
2nd Reading4
Committee5
Report6
3rd Reading7
Royal AssentSummary
Tests whether drug-price transparency is a non-partisan issue. Backed by patient-advocacy groups; opposed by industry.
Legislative history
- First reading
First reading in the House of Commons.
- Introduced
Tabled in the originating chamber by the sponsor.
- First reading
Bill formally introduced; printed text becomes available.
Sponsored by
Michael ChongCONSERVATIVEOfficial source
Read full text on Parliament of Canada